GAS2 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, the BCR-ABL1-dependent increase of GAS2, whose overexpression has been linked with CML progression, impairs the alternative route to beta catenin degradation by calpain [11], [46].